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ABSTRACT
Objective: The aim of this study was to investigate, for the first time, the possible in vivo genotoxic and carcinogenic activity associated with exposure to 
norgestrel (NGT) drug through employing the very recently established and adjusted genotoxic and tumorigenic methods in Drosophila melanogaster.
Methods: Two in vivo genotoxic test systems were used; one detects the somatic mutation and recombination effects (somatic mutation and 
recombination test [SMART] wing-spot test) and the other detects the primary DNA damage (the comet test) in the body cells of D. melanogaster. On 
the other hand, the warts (wts)-based SMART assay is a vital genetic examination in Drosophila used to identify and characterize cancer potential of 
compounds.
Results: Four experimental doses of NGT were used (ranging from 0.24 µM to 16 µM). NGT was found to be non-genotoxic at all tested concentrations 
even at the highest dose level 16 µM and failed to increase the frequency of tumors in the somatic cells of D. melanogaster.
Conclusion: Our results strengthen the hypothesis that steroidal drugs might act through a non-genotoxic carcinogen mechanism where the 
carcinogenic properties occur by direct stimulation of cellular proliferation through a steroid receptor-mediated mechanism. In addition, the results 
obtained in this research work may contribute to highlighting the importance of NGT as a potent neuroprotective antioxidant drug.
Keywords: Norgestrel, Wing-spot assay, Comet assay, Warts-based somatic mutation and recombination test.
INTRODUCTION
Norgestrel (NGT) is a synthetic progestin drug that is widely used 
as an oral contraceptive drug alone or in combination with synthetic 
estrogen to deal with several cases of hormonal disturbances in 
women [1,2]. In recent times, several clinical studies have revealed 
that NGT is a powerful neuroprotective antioxidant agent, successfully 
protect photoreceptor cells from morphological changes associated 
with exposure to high levels of reactive oxygen species [3,4]. In 
addition, this hormonal drug maintains retinal function through 
increasing the expression of basic fibroblast growth factor that has 
been shown to be protective in different experimental models of 
neurodegeneration [3-5].
Like all the synthetic progestins, this drug spreads throughout the 
cell membrane forming complexes with nuclear receptors within 
the cytoplasm, which pass through nuclear pores and initiate gene 
expression [1,6]. Nevertheless, several medical studies have indicated 
that long-term exposure to synthetic progestins/oral contraceptives 
increases the likelihood of occurrence of various types of cancer in 
humans [7]. In addition, treatment with progestins leads to reduce the 
latency of a breast tumor and increases tumor growth [8,9].
It has been demonstrated that various types of synthetic progestins, 
such as chlormadinone acetate, medroxyprogesterone acetate, 
and norethynodrel have a DNA damaging property, as evidenced 
by chromosomal damage and induction of SCEs [7,10,11]. 
However, the available data regarding the mutagenicity of NGT are 
inconclusive because both positive and negative results have been 
reported [6,12]. Furthermore, the authors [12,13] found that the 
positive genotoxic effects of NGT are only produced in the presence 
of a metabolic activation system, and the reactive metabolites of 
it might be in command of its genotoxicity. In the same domain, 
metabolic activation of steroidal drugs produces reactive oxygen 
species, which can alter the DNA structure resulting in mutations 
and induces cancer [12,14].
Drosophila was selected in this inquiry because it is seen as a good 
in vivo model system for testing genetic toxicology. In this context, the 
role of Drosophila is time-efficient, allowing a rapid genotoxic analysis, 
when compared to rodents. Moreover, it has a metabolic system fit for 
activation of mutagenic and carcinogenic agents similar to the liver in 
mammals [15]. Further, fruit flies develop overgrown tissue that looks 
very similar to a human tumor when certain genes are mutated. Unlike 
tissue culture work, the fly tumor can be induced in the context of intact 
epithelia, which is comparable to human tumors [16]. Furthermore, 
in light of the fact that Drosophila has no nuclear progesterone 
receptor [17], so the NGT drug cannot produce an effect through the 
cellular proliferation pathway.
The aim of this study was to investigate, for the first time, the possible 
in vivo genotoxic and carcinogenic activity associated with NGT 
exposure by employing the very recently established and adjusted 
genotoxic and tumorigenic methods in Drosophila melanogaster. On the 
one hand, we used two methods in this work to detect the genotoxic 
effect; one detects the somatic mutation and recombination effects 
(somatic mutation and recombination test [SMART] wing-spot test), 
whereas the other detects the primary DNA damage (the comet test). On 
the other hand, to determine if the changes induced in DNA by this drug 
were not only recombinogenic but also an enhancer of tumor growth, 
we used warts (wts)-based SMART assay. This method is a vital genetic 
examination in Drosophila used to identify and characterize cancer 
potential of compounds [18]. Since this synthetic progestin is used on a 
large scale, thus there is a requirement to add more information on its 
mutagenic activity and its possible dangers to human health.
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2018.v11i10.27374
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METHODS
Chemicals and dose selection
NGT (CAS No.6533-00-2) was purchased from (Cayman Chemical 
Company, MI, USA) with purity ≥95%. It was dissolved in dimethyl 
sulfoxide (DMSO) (DMSO, CAS No. 67-68-5, Hi-Media Pvt. Limited, 
Mumbai, India), which acts as a negative control at a final concentration 
0.2% in Drosophila food according to Nazir et al. 2003 [19]. The 
control larvae received normal Drosophila food. Mitomycin C (MMC, 
CAS No. 50-07-7), was purchased from Kyowa Hakko. Co. Ltd. (Tokyo, 
Japan) used as positive control, was dissolved in double-distilled water 
to the concentration used, just before the treatment. The concentration 
of MMC used in this experiment was based on studies of the mitotic 
recombination in D. melanogaster (third instar larvae), induced by 
MMC [20]. Phenylthiourea (PTU, CAS 103-85-5, ≥95% purity) were 
obtained from Sigma-Aldrich (USA); N-lauroylsarcosine sodium 
hydroxide and Triton X-100 were from Fluka Chemical AG (Buchs, 
Switzerland); low melting point agarose (LMA), normal melting-point 
agarose (NMA), sodium hydroxide, and sodium chloride were from Carl 
Roth GmbH (Karlsruhe, Germany); the Ca2+ and Mg2+ free phosphate-
buffered saline (PBS), Tris buffer, and 4/,6- Diamidine-2-phenylindole 
(DAPI) were from HiMedia Laboratories Pvt., Ltd., (Mumbai, India).
The concentrations of NGT tested in the present study ranged from 
0.24 µM to 16 µM. All concentrations lie within the scope of clinical 
doses in humans with the exception of the highest dose, which 
corresponded to 10-fold the maximal therapeutic dose of NGT. NGT was 
dissolved in DMSO at 0.2% final concentration. DMSO was used as a 
negative control, while MMC 50 µM was used as a positive control.
Drosophila strains
The following D. melanogaster strains were used in this study: The 
multiple wing-hair strain mwh, the flare-3 strain with a genetic 
structure flr3/TM3, the wild-type (Oregon R+), and wts (wts/TM3, Sb1). 
The first two strains were used for the wing-SMART assay. According 
to the comet assay, we used the wild-type (Oregon R+). The strain 
wts/TM3, Sb1 was used for the wts-based SMART assay, which carries 
one lethal allele wts on chromosome 3, balanced by a TM3 chromosome, 
having multiple inversions, characterized by dominant stubble (Sb) 
mutation, phenotypically identified by the short bristles [21]. The 
flies and larvae in all experiments were cultured at 25±1°C with 60% 
humidity on standard Drosophila food containing agar, cornmeal, sugar, 
and yeast as described by Dhanraj et al. 2017 [22].
Wing-spot test
Virgin females of the flr3 strain were mated to mwh males as previously 
described by Marcos and Carmona 2013 [23]. Eggs from this cross 
were collected during 8 h periods in culture bottles containing the 
standard Drosophila food. The third instar larvae from this cross were 
placed in glass flasks containing standard Drosophila food and treated 
with different concentrations of NGT. The larvae were fed on this 
medium until pupation. All experiments were performed at 25±1°C 
and at approximately 60% of relative humidity. The emerged flies were 
collected from the treatment vials and stored in 70% ethanol. Afterward, 
their wings were carefully removed, mounted in Faure’s solution 
on microscope slides and inspected, under ×400 magnifications, for 
the presence of small single spots, large single spots, and twin spots 
according to the method of Graf et al. 1984 [24]. In each series, we 
examined 80 wings (40 individuals). The scoring of flies and data 
evaluation were conducted following the standard procedures for the 
wing spot assay, as used in the investigation of Demir et al. 2010 [25].
Comet assay
Third-instar larvae (72±4-h-old) were transferred to standard 
Drosophila food containing different concentrations of NGT, ranging 
from 0.24 µM to 16 µM. Larvae were fed on this medium during 24±2 h. 
All the experiments were performed at 25±1°C and at ∼60% relative 
humidity. D. melanogaster hemocytes were collected according to the 
standard technique proposed by Marcos and Carmona 2013 [23]. 
Chilled larvae (96±2-h-old) were removed from food media, washed 
in water, and sterilized in 5% bleach and dried. The cuticle from 40 to 
60 larvae was then disrupted with two fine forceps. The hemolymph 
and circulating hemocytes were directly collected in cold PBS solution 
containing 0.07% PTU and separated in a 1.5 mL microcentrifuge tube. 
Pooled hemolymph was centrifuged at ×300 g for 10 min at 4°C; the 
supernatant was discarded and the pellet was resuspended in 20 µL 
of cold PBS.
The comet assay was performed as previously described by Singh et al. 
1988 [26] with slight changes. Cell samples (∼40,000 cells in 20µL) 
were carefully resuspended in 140 µL of 0.75% LMA, layered onto 
microscope slides pre-coated with 150 µL of 1% NMA (dried at room 
temperature). Two gels were mounted on each slide and covered with 
a coverslip. Immediately after agarose solidification (10 min at 4°C), 
the coverslips were removed and the slides were immersed in cold, 
freshly made lysis solution (2.5 M NaCl, 100 mM Na2EDTA, 10 mM Tris, 
1% Triton X-100, and 1% N-lauroylsarcosine, pH 10) for 2 h at 4°C in 
a dark chamber. DMSO was omitted from the lysis solution because it 
has been considered unnecessary for Drosophila tissues, and DMSO at 
low concentrations is cytotoxic in Drosophila [15]. To avoid additional 
DNA damage, the next steps were performed under dim light. Slides 
were placed for 25 min in a horizontal gel-electrophoresis tank filled 
with cold electrophoresis buffer (1 mM Na2EDTA, 300 mM NaOH, 
pH 13) to allow DNA unwinding. Electrophoresis was carried out in 
the same buffer for 20 min at 25 V and 300 mA. The unwinding and 
electrophoresis were done at 4°C. After electrophoresis, slides were 
neutralized with two washes of 5 min with 0.4 mM Tris (pH 7.5). The 
slides were stained with 20 µL of DAPI (1µg/mL) per gel. The images 
were examined at 400× with a Komet 5.5 Image-Analysis System 
(Kinetic Imaging Ltd., Liverpool, UK) fitted with an Olympus BX50 
fluorescence microscope equipped with a 480–550-nm wide-band 
excitation filter and a 590-nm barrier filter. One hundred and fifty 
cells were examined (25 cells/slide from two slides per experimental 
group, three experiments per group). The percentage of DNA in the 
tail (%DNA tail) was used to measure DNA damage, because this is 
the most widely used and recommended parameter for comet-data 
analysis [27,28].
Warts-based SMART assay
To obtain wts/+heterozygote larvae, virgin females carrying one copy of 
the mutant tumor suppressor allele and a balancer chromosome (TM3, 
Sb1) were crossed with wild-type (Oregon R+) males as previously 
described by Eeken et al. 2002 [21]. The eggs of the descendants were 
collected during an 8 h period. After 72±4 h, the third-instar larvae 
were washed in reverse osmosis water and collected using a fine mesh 
sieve. The larvae from this cross were treated with NGT. The larvae 
were placed in glass flasks containing standard Drosophila food and 
different concentrations of NGT and were allowed to grow on it. The 
larvae were submitted to a chronic treatment for approximately 48 h. 
However, only adult flies, without the chromosome balancer (TM3, 
Sb1) were analyzed for tumor clones and they did not have truncated 
bristles. Scoring of wts was conducted according to Abou-Eisha et al. 
2016 [14].
Statistical analysis
The conditional binomial test according to Kastenbaum and Bowman 
1970 [29] was applied to assess differences between the frequencies 
of each type of spot in treated and concurrent negative control flies 
with 5% significance levels. For evaluation of the induced effects, the 
multiple-decision procedure described by Frei and Würgler 1988 [30] 
was used to judge the overall response of an agent as positive, weakly 
positive, negative, or inconclusive. Differences in the percentage of 
DNA damage in the tail of different treatment groups were compared 
with those of the control, using the general linear model (GLM). The 
GLM approach is analogous to the traditional ANOVA, but it allows 
the use of non-normal data, which is our case [15]. Before analysis 
with GLM, the homogeneity of variance and normality assumption 
of data was tested with the Bartlett and Kolmogorov–Smirnov tests, 
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respectively. For multiple comparisons between groups, the Tukey’s 
HSD test was carried out. On the other hand, the statistical significance 
of the differences between tumor frequencies in the treatment and 
control was calculated using the non-parametric Mann–Whitney 
U-test. Statistical significance was set at p≤0.05. Data analyses were 
performed using SAS program (v9.3, SAS Institute Inc., Cary, NC, USA).
RESULTS
The different clinical concentrations utilized in experiments to 
examine the genotoxicity and tumorigenic potentials were appropriate 
for larval viability. The viability of larvae was more than 70% at 
concentrations ranged from 0.24 µM to 1.6 µM except for the highest 
concentration 16 µM, viability was lessening, but it was sufficient to 
perform these experiments where viability was higher than 50%. 
Elevated toxicity observed at the highest concentration 16 µM shown 
in both a lessened proportion of larvae developing into grown-ups 
and a lateness within the time wanted for the larvae to progress into 
the grown-up stage.
The data obtained from the experiment assigned to examine the 
genotoxicity of NGT in the wing-spot assay are shown in Table 1. The 
attained results revealed that NGT did not produce a significant increase 
at all tested concentrations in the frequency of the three mutant spots 
(small single, large single, and twin spots) in comparison with negative 
control. On the contrary, the results obtained with MMC showed a 
positive response, which supports the accurate performance of this 
method, and the validity of the negative data found with this hormonal 
drug examined in this assay.
In the same vein, the results observed in the comet test after treatment 
of larvae of D. melanogaster with four concentrations of NGT to test 
the genotoxicity are shown in Fig. 1. NGT was given to the larvae 
(72±4-h-old) for (24±2 h) at doses ranging from 0.24 µM to 16 µM. The 
results indicated that none of the tested doses induced a significant 
increment of DNA damage represented as the percentage of DNA in the 
tail on Drosophila hemocytes when compared with the negative control. 
On the other hand, the positive control with 50 µM of MMC demonstrated 
a sharp increment of DNA damage on hemocytes, which strengthen the 
acceptability of the negative results determined during this work. In 
summary, our in vivo genotoxicity data with this synthetic progestin 
indicate that it is not genotoxic with these assays (wing spot test and 
comet assay), at least under the experimental conditions applied.
NGT was tested for its ability to cause tumors by applying the wts-based 
SMART method on D. melanogaster. This precise method used in the 
fruit fly gives a clear picture of whether a substance has the capability 
of inducing cancer-causing risk to humans or not. The results revealed 
that there was no significant difference among the tumor frequencies 
found at all examined concentrations of NGT and the negative control. 
Thus, suggesting an absence of the oncogenic potential of this hormonal 
drug (Table 2). Nevertheless, the frequencies of tumor induction 
exhibited a highly significant increase after feeding the Drosophila 
larvae with MMC treatment, thus confirming the validity of wts-based 
SMART experiment and the results obtained.
DISCUSSION
In the present study, to increase our information about the possible 
genotoxic hazard correlated with NGT, we employed two recognized 
in vivo methods to assess the genotoxicity of NGT in somatic cells 
of Drosophila. On the single hand, the wing-spot test is a method 
depending on the loss of heterozygosity production that might take 
place through several ways, such as a wide range of mutational 
events as well as mitotic recombination. This outstanding technique 
detects concurrently mutational and mitotic recombination, being 
able to enumerate the recombinogenic activity of a substance in a 
genotoxicity screening [31]. In the same vein, the comet experiment 
is an outstanding technique broadly utilized for in vivo mutagenicity 
screening, since it can employ to a varied variety of cells, it can detect 
lesser amounts of DNA impairment and can identify various kinds of 
DNA damage [32]. Hence, this assay is being frequently used effectively 
to measure DNA damage in different cells and model organisms, 
including D. melanogaster [33]. On the other hand, NGT examined for 
carcinogenic activity by applying the wts-based SMART technique on 
D. melanogaster as transgenic model organisms. This method is one 
of the famous SMART analysis in Drosophila, where any mutation 
that results in a lack of function of wts gene might cause a noticeable 
phenotypes changes in the eyes and wings of the fly. This test is based 
Table 1: Induction of wing spot in Drosophila after larval treatment with NGT 










N Fr D N Fr D N Fr D N Fr D
Control 80 22 0.28 1 0.01 0 0.00 23 0.29
DMSO 0.2% 80 24 0.30 − 2 0.03 i 0 0.00 i 26 0.33 −
NGT
0.24 80 16 0.20 − 2 0.03 i 0 0.00 i 18 0.23 −
1 80 16 0.20 − 3 0.04 i 0 0.00 i 19 0.24 −
1.6 80 19 0.24 − 2 0.03 i 0 0.00 i 21 0.26 −
16 80 21 0.26 − 2 0.03 i 0 0.00 i 23 0.29 −
MMC 
50 80 60 0.75 + 31 0.39 + 15 0.19 + 106 1.33 +
N: Number, Fr: Frequency, D: Statistical diagnosis according to Frei and Würgler (1988), +: Positive, −: Negative, i: Inconclusive, m: Multiplication factor, levels of 
probability α=0.05. DMSO: Dimethyl sulfoxide; MMC: Mitomycin C, NGT: Norgestrel 
Fig. 1: Primary DNA damage measured by the in vivo comet assay 
in hemocytes from Drosophila melanogaster larvae treated with 
norgestrel. Dimethyl sulfoxide 0.2% was used as negative control 
and mitomycin C as positive control. ***p<0.001, ns: No significant 
against negative control
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on the wts gene, which is straightforwardly included in control of the 
cell cycle and its analogous are tumor suppressor genes present in 
some lower organisms in addition to mice and human [18]. Exposure 
of wts heterozygous individuals in larval stage to carcinogenic or 
mutagenic factors leads to loss of heterozygosity in some epithelial 
cells, which causes to induce tumors that could be recorded in adult 
insects [21]. Furthermore, the authors [18,21] reported that this 
technique displayed high sensitivity to a broad spectrum of mutagenic 
and carcinogenic compounds.
In this research work, no genotoxic effects of the synthetic progestin 
NGT have been detected in the D. melanogaster SMART wing-spot 
test (Table 1) as well as the comet assay (Fig. 1). In agreement 
with our results, treatment of the Syrian hamster embryo cells 
that do not have any measurable levels of the nuclear androgenic 
receptor with NGT or diethylstilbestrol failed to induce DNA 
damage, chromosome abnormalities, and gene mutations [34]. In 
addition, the synthetic progestin levonorgestrel did not increase 
point mutations in the Ames Salmonella/microsome test with or 
without a metabolic activation system [35]. In addition, the same 
author obtained negative results in chromosomal aberration test in 
an in vitro Chinese hamster ovary cells and an in vivo micronucleus 
assay in mice. In the same sense, several authors recorded negative 
results in the comet test on different types of human cell lines 
treated with oral contraceptive drugs [36,37]. However, Ahmad et al. 
2001 [6] reported that NGT-induced sister chromatid exchanges 
and chromosomal abnormalities in human lymphocytes in vitro 
and significantly increase mitotic index with and without metabolic 
activation system. In the same regard, Siddique et al. 2006 [13] also 
observed the same finding but only in the presence of a metabolic 
activation medium.
On the other hand, our results showed that there was no significant 
difference (p>0.05) among the tumor frequencies found at all examined 
doses of NGT and the negative control in the wts-based SMART assay, 
thus suggesting an absence of cancer-causing action of NGT (Table 2). 
In agreement with this finding, Backman et al. 2005 [38] reported that 
Finnish female users of the synthetic progestin levonorgestrel did not 
show an increase in the incidence of breast cancer when compared 
with the average. Moreover, the steroidal drug 17β-estradiol was found 
to be nongenotoxic at all tested concentrations and failed to increase 
the frequency of tumors in the somatic cells of D. melanogaster [14]. 
However, NGT significantly upraised the protein expression of CD44, 
an important cancer stem cell marker in tumor cells [6]. In the 
same context, Kresowik et al. 2008 [39] found that levonorgestrel 
led to increasing endometrial thickness during the usage of the 
levonorgestrel-releasing intrauterine system. Like all the synthetic 
progestins, NGT has an affinity for binding to the progesterone 
receptors [40]. Similar to progesterone hormone, NGT, when binding 
with progesterone receptors stimulates gene transcription as well as 
influencing cell proliferation and differentiation in target tissues [41]. 
In this regard, NGT stimulates MCF-7 breast cancer cell growth by 
activating the estrogen receptor [42]. Further, NGT was found to 
increase significantly the frequency of tumor growth and metastasis 
of BT-474 human breast cancer cells implanted in nude mice [43]. 
In the same sense, the previous authors found that NGT stimulates 
expression of vascular endothelial growth factor and CD34 expression 
in BT-474 xenograft tumors suggesting that it promotes tumor 
vascularization.
The absence of genetic toxicity in the current study can be attributed to 
the approved powerful antioxidant effect of NGT, where it prevents the 
production of reactive oxygen species in the cells [4]. In this context, 
reactive oxygen species can change the structure of DNA forming 
mutagenic injuries or producing chromosomal abnormalities, which 
can cause mutations and induce cancer [14]. NGT acts as an antioxidant 
agent through modulating the nuclear factor erythroid 2-related 
factor 2 (Nrf2) [4]. In this regard, Nrf2 works as a cytoprotective 
factor controlling the expression of the genes responsible for the 
production of antioxidants, anti-inflammatory, and detoxifying 
proteins [4,44]. Further, the mammalian Nrf2 falls under the category 
Cap “n” Collar (Cnc) bZIP family of transcription factors and has a high 
degree of compatibility with the transcription factor CncC present in 
D. melanogaster [44].
Moreover, obtained negative results may also be explained by 
the high efficacy of the biotransformation mechanisms for toxins 
in Drosophila. Biotransformation of quinones and xenobiotic 
substances takes place through glutathione conjugation 
reaction [45,46] in which that reaction mostly includes glutathione-
S-transferase that shows an essential job in the formation of 
glutathione conjugates of catechol estrogen quinones [47]. In this 
regard, several authors [48,49] demonstrated that glutathione plays 
a crucial task in diminishing the harmful effects of catechol estrogen 
quinones. In addition, in D. melanogaster, glutathione-S-transferase 
does the same role of glutathione peroxidase enzyme to carry out 
the protection against oxygen-mediated damage probably because 
of the absence of peroxidase enzyme in Drosophila [50]. It is worth 
to be mentioned that different stages in the life cycle of a Drosophila 
have a considerable quantity of the glutathione-S-transferase 
enzyme [51]. Furthermore, the same authors reported that larval 
stage showed the most elevated particular action of glutathione-
S-transferase. In view of this point, it appears to be sensible to 
consider that the great amount of glutathione-S-transferase in 
larval stage might encourage the detoxifying mechanism of NGT 
metabolites and the produced reactive oxygen species. This would 
result in both the absence of genotoxicity and tumor frequencies in 
D. melanogaster.
CONCLUSION
The data recorded in this investigation revealed that synthetic 
progestin NGT is not able to induce both genotoxic and carcinogenic 
effects in somatic cells of D. melanogaster. Our results strengthen 
Table 2: Frequency of tumor clones observed in heterozygous offspring of D. melanogaster after treatment with NGT
Treatment concentration (µM) Total flies scored No. of tumors scored Frequency (No. of 
tumors/fly)Eyes Head Wing Body Leg Halter Total
Control 200 1 0 11 7 4 0 23 0.115
DMSO 0.2% 200 0 4 6 9 3 0 22 0.110
NGT
0.24 200 0 0 4 8 3 1 16 0.080
1 200 1 2 5 8 2 0 18 0.090
1.6 200 3 1 3 9 3 0 19 0.095
16 200 3 2 3 8 4 0 20 0.100
MMC
50 200 83 39 114 123 59 12 430 2.15**
Analysis of tumor frequency data is identified by the Mann–Whitney U-test. Levels of probability indicated as *p<0.05, **p<0.01, and ***p<0.001 comparing with 
negative control. DMSO: Dimethyl sulfoxide, MMC: Mitomycin C, NGT: Norgestrel, D. melanogaster: Drosophila melanogaster
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the hypothesis that steroid drugs might act through a non-genotoxic 
carcinogen mechanism where the carcinogenic properties occur by 
direct stimulation of cellular proliferation through a steroid receptor-
mediated mechanism. Eventually, these negative results could 
emphasize recently reported observations that found NGT drug as a 
potent neuroprotective antioxidant agent.
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